Monday, December 23, 2024
HomeTagsIV

IV

AcelRx Pharma Highlights Advantages of the Sufentanil Sublingual Tablet in Joint Replacement Surgery

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced...

Mitsubishi Tanabe Pharma America Announces FDA Acceptance of New Drug Application (NDA) for Oral Edaravone Formulation for the Treatment of ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics